학술논문

Genetic screen in a large series of patients with primary progressive aphasia
Document Type
article
Source
Alzheimer's & Dementia. 15(4)
Subject
Biomedical and Clinical Sciences
Biological Psychology
Clinical Sciences
Neurosciences
Psychology
Dementia
Alzheimer's Disease Related Dementias (ADRD)
Aging
Genetics
Frontotemporal Dementia (FTD)
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Alzheimer's Disease
Brain Disorders
Neurodegenerative
Acquired Cognitive Impairment
Clinical Research
Aphasia
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Neurological
Aged
Aphasia
Primary Progressive
C9orf72 Protein
Cohort Studies
DNA-Binding Proteins
Female
Frontotemporal Dementia
Humans
Male
Middle Aged
Mutation
Progranulins
Primary progressive aphasia
C9orf72
GRN
TARDBP
Geriatrics
Clinical sciences
Biological psychology
Language
Abstract
IntroductionPrimary progressive aphasia (PPA) is a neurological syndrome, associated with both frontotemporal dementia and Alzheimer's disease, in which progressive language impairment emerges as the most salient clinical feature during the initial stages of disease.MethodsWe screened the main genes associated with Alzheimer's disease and frontotemporal dementia for pathogenic and risk variants in a cohort of 403 PPA cases.ResultsIn this case series study, 14 (3.5%) cases carried (likely) pathogenic variants: four C9orf72 expansions, nine GRN, and one TARDBP mutation. Rare risk variants, TREM2 R47H and MAPT A152T, were associated with a three- to seven-fold increase in risk for PPA.DiscussionOur results show that while pathogenic variants within the most common dementia genes were rarely associated with PPA, these were found almost exclusively in GRN and C9orf72, suggesting that PPA is more TDP43- than tau-related in our series. This is consistent with the finding that PPA frequency in dominantly inherited dementias is the highest in kindreds with GRN variants.